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A validated capillary gas chromatography method for guaco 
(Mikania glomerata S.) quality control and rastreability:
from plant biomass to phytomedicines
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RESUMO: “Método validado por cromatografia gasosa capilar para o controle de qualidade 
e rastreabilidade de guaco (Mikania glomerata S.): da matéria-prima ao fitoterápico”. Este 
trabalho descreve a validação completa de metodologia analítica empregando cromatografia 
gasosa capilar com padronização interna para quantificação da cumarina (1,2-benzopirona) em 
produtos contendo guaco (Mikania	glomerata	Spreng - Asteraceae): xarope, planta e extrato 
padronizado, além do estudo de estabilidade do fitoterápico em questão. Utilizou-se uma coluna 
capilar HP-5 (30 m x 0,32 mm x 0,25 µm), hidrogênio a 1,8 mL/min e rampa de temperatura de 
100 °C a 250 °C, a 15 ºC/min. A temperatura do injetor (split 1:20) foi de 250 °C, enquanto a 
do detector foi de 270 °C. Os tempos de retenção dos padrões foram: 2,86 minutos para o 1, 2, 
3, 4-tetrametilbenzeno, 4,45 minutos para o piperonal (padrões internos) e 5,36 minutos para a 
cumarina. Após o procedimento de extração da planta in	natura, a recuperação da cumarina foi de 
101,6 %, enquanto que para o xarope esta foi de 100,8 %. Os limites de detecção e quantificação 
foram 0,5 µg/mL e 1,5 µg/mL, respectivamente. A precisão, determinada para todas as amostras, 
apresentou desvios padrões relativos menores que 2,5 %. Os teores de cumarina presentes nas 
folhas, extrato e xarope foram de 0,38 % m/m, 1,33 mg/mL e 0,143 mg/mL, respectivamente. 
Unitermos: Mikania	 glomerata, Asteraceae, cumarina, cromatografia gasosa, validação de 
métodos, xarope.
ABSTRACT: This work describes a full validation of a capillary gas chromatography analytical 
methodology using internal standardization for the quantification of coumarin (1,2-benzopyrone) 
in guaco (Mikania	 glomerata	 Spreng - Asteraceae) products: syrup, plant and its extract, 
including the stability study of the phytomedicine. For the analysis, it was used an HP-5 
capillary column (30 m x 0.32 mm x 0.25 µm), hydrogen at a flow rate of 1.8 mL/min and the 
increasing temperature gradient was: 100 °C to 250 °C, 15 ºC/min. The temperature of injector 
(split 1:20) and detector were kept at 250 °C and 270 °C, respectively. The retention times of 
the standards for the above conditions were 2.86 minutes for 1, 2, 3, 4-tetramethylbenzene, 
4.45 min for piperonal (internal standards), and 5.36 minutes for coumarin. After extraction 
procedure, the recovery of coumarin determined for plant raw material was 101.6 %, while 
for syrup it was 100.8 %. Detection and quantification limits were 0.5 µg/mL and 1.5 µg/mL, 
respectively. Precision was determined for all samples and the results were lower than 2.5 %. 
The total amount of coumarin in plant raw material, its extract and syrup were 0.38 % w/w, 1.33 
mg/mL and 0.143 mg/mL, respectively. 
Keywords: Mikania	glomerata, Asteraceae, coumarin, gas chromatography, method validation, 
syrup.
INTRODUCTION
Since earlier times, medicinal plants are used 
for the treatment of human diseases and nowadays 
they still make an important key for primary health 
care. It was observed that, in the last years, it has been 
an increasing interest by the large companies and 
some governments in such products, stimulating their 
standardization and the development of reliable quality 
control analytical methodologies to support their safety 
and efficacy (WHO, 1998; Calixto, 2000; Springfield et 
al., 2005; Ferrante et al., 2007; Migliato et al., 2007; 
Chaves & Costa, 2008; Engel et al., 2008).
Traditionally, for medicinal plants, these 
analytical methodologies include classical physical-
chemical assays, like identification, water content, 
chemical assay of active compounds, total/insoluble 
ash, etc. (Calixto, 2000; Ong, 2004). Furthermore, for 
herbal preparations, some tests include quantification 
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of the active compounds and uniformity of dosage, 
disintegration, dissolution among others (Ong, 2004). 
Concerning the quantification assay and considering the 
high complexity of this type of matrix, special attention 
has been given to chromatographic techniques, mainly 
gas chromatography (GC) and high-performance liquid 
chromatography (HPLC), due to their advantages such 
as good separation, efficiency and speed properties 
(WHO, 1998; Ribani et al., 2004; César et al., 2007; 
Sousa et al., 2007; Chang et al., 2008). 
The specie	 Mikania	 glomerata Spreng 
(Asteraceae), popularly known in Brazil as ‘guaco’, 
is widely used as expectorant and to treat respiratory 
diseases, as well as against fever, syphilis, neuralgia and 
rheumatism (Corrêa, 1984; Agra et al., 2008; Marliére 
et al., 2008). Studies reported by Soares de Moura et al. 
(2001) and Corrêa et al. (2008) supported the indication 
of M.	glomerata products for the treatment of respiratory 
diseases where broncoconstriction is present, while 
Fierro et al. (1999) showed the anti-allergenic effects 
of guaco extract. The described biological effects are 
mainly due to the presence of coumarin in this plant 
(Vilegas et al., 1997b; Rocha et al., 2008). 
Also, the use of this specie, its therapeutic 
indication and safety are validated by the Simplified 
Register list of the Brazilian Health Surveillance Agency 
(Agência Nacional de Vigilância Sanitária/ANVISA) 
and Brazilian Pharmacopoeia (Brasil, 2004; Brandão et 
al., 2006 and 2008; Carvalho et al., 2008).
Despite the extensive use of guaco extracts, it 
was found that there is a lack concerning the availability 
of validated methods for the quantitative analysis of 
coumarin in phytomedicines containg guaco extracts, 
especially syrups. Furthermore, there is no procedure 
described for monitoring of the entire manufacturing 
process, which includes the acquisition of the raw 
material until the production and standardization of 
extracts. Nonetheless, the quality control is based 
on the quantification of the coumarin in the crude 
plant and in its extracts, through the application of 
chromatographic techniques, as suggested by Vilegas et 
al. (1997a), Celeghini et al. (2001), Dos Santos et al. 
(2006) and Taleb-Contini et al. (2006). Another recent 
method for the quantification of coumarin in guaco fluid 
extract and tinctures was performed by first derivative 
spectrophotometry by Osório and Martins (2004) and 
Silva et al. (2008). 
Therefore, this work reports a single and 
simply capillary GC method, developed and validated 
with internal standardization, for the quantification of 
the coumarin 1,2-benzopyrone in guaco crude plant 
material, its extract and its commercial syrup, allowing 
the rastreability of results, including the stability study 
of the final formulation. 
MATERIAL AND METHODS
Drugs and solvents
All solvents used for chromatographic 
purposes were chromatographic grade. Absolute 
ethanol, ethyl acetate and hexane were supplied by 
Merck Co (Darmstadt, Germany). The pure synthetic 
coumarin (1,2-benzopyrone) 99 % was supplied by 
Fluka Co (St. Louis, MO, USA). Piperonal was supplied 
by Sigma-Aldrich (St. Louis, MO, USA) and 1, 2, 3, 
4-tetramethylbenzene was acquired from Merck Co 
(Darmstadt, Germany).
Plant material, extract and syrup
Authentic leaves and branch tips of M.	
glomerata	 were purchased from Quimer Comércio 
de Ervas Ltda (São Paulo, SP, Brazil). The dried raw 
material was grounded to a fine powder using a knife 
mill, and it was homogenized using a 30 mesh sieve. 
The standardized guaco extract in aqueous ethanol (1:3) 
was obtained by maceration and percolation, yielding 
5.5 % w/v of crude extract. In addition, three batches of 
guaco syrup containing 10.0 % v/w were prepared with 
this standardized extract. 
Sample preparation
For guaco extract, 10.0 mL of the sample 
were transferred to a volumetric flask containing 
10.0 mg of piperonal. After complete dissolution, the 
sample was diluted 10 times in ethanol, from which an 
aliquot of 1.0 µL was injected into the GC apparatus. 
Concerning plant material, 0.500 g of powdered dried 
leaves and branch tips were transferred to a 50.0 mL 
sealed Erlenmeyer flask and macerated with 20.0 mL 
of ethanol, containing 200 µg/mL of piperonal, for two 
hours in a shaker at 120 rpm and at 40 °C. After that, 
the sample was cooled down to room temperature and 
filtered through an analytical filter paper. Finally, for 
syrup, 10.0 g of the sample and 20.0 mL of ethyl acetate, 
containing 100 µg/mL of piperonal, were transferred to 
a 50.0 mL Erlenmeyer flask. The flask was hermetically 
sealed and kept in a magnetic stirrer for 30 minutes at 
40 ºC. After that, the sample was cooled down to room 
temperature, and submitted to centrifugation at 20028 x 
g for three minutes. An aliquot of the supernatant (2.0 
mL) was transferred to a vial for further GC analysis.
Chromatographic conditions
Chromatographic analysis was carried out with 
a Hewlett-Packard 6890N gas chromatograph (Agilent 
Technologies, Inc.) equipped with a split/splitless 
injector inlet and a flame ionization detector. The output 
was recorded using the workstation which plotted and 
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integrated the chromatographic data. An HP-5 capillary 
column (30 m of length x 0.32 mm of internal diameter 
x 0.25 µm of film thickness) was used for the analysis. 
Hydrogen at a flow rate of 1.8 mL/min was employed as 
the carrier gas and the increasing temperature gradient 
was:  100 °C to 250 °C, 15 ºC/min. Nitrogen was used 
as the detector makeup gas at a flow rate of 1.8 mL/
min. The temperatures of the injector (split 1:20) and 
detector were kept at 250 °C and 270 °C, respectively. 
Method validation
First of all, the specificity was determined by 
analyzing the chromatographic profile (retention time 
and resolution) of the samples (plant, extracts and 
syrup). Also, a placebo formulation (syrup free of plant 
extract) and a placebo solution enriched with 0.25 mg/g 
of coumarin were compared to an ethyl acetate solution 
containing only the standard compound (coumarin), in 
order to verify the interference of matrix constituents. 
The linearity responses were determined 
by injecting ten different concentrations of the 
standards mixture into the GC apparatus. The 
solutions of the standards (coumarin, piperonal and 
1,2,3,4-tetramethylbenzene) were prepared in ethanol, 
followed by serial dilution to achieve concentrations 
ranging from 15.0 µg/mL to 500.0 µg/mL. The obtained 
linear correlations were: 0.9993 for coumarin (y = 
3.0186x – 36.175), 0.9993 for piperonal (y = 1.517x 
+13.592), and 0.9995 for 1,2,3,4- tetramethylbenzene 
(y = 2.758x +27.126).
The detection and quantification limits were 
defined as the lowest concentration of the analyte that 
can be detected and quantified above the noise level 
of the system, respectively. Both were determined by 
analyzing the residual standard deviation of the linear 
regression of three analytical curves. 
Precision was determined by preparing and 
analyzing six samples comprising plant material, extract, 
syrup and standard solution at a concentration of 200 
µg/mL. For that, samples were prepared accordingly to 
the method described above. The data, obtained under 
de same experimental conditions, were expressed by the 
standard deviation of the measures.
For plant material, the accuracy determination 
was undertaken at the three nominal concentrations (n = 
4), like described in the recovery procedure, performing 
a standard concentration of 0.50 %, 1.00 % and 2.00 % 
of coumarin in the leaves, respectively. The accuracy 
determination for the syrup was performed in six 
replicates (n = 6) at a concentration of 0.260 mg/g. The 
accuracy or measure of bias was calculated from the 
expression: 
( ) )[ ] )(100((%) valuetruevaluetruevaluemeasuredBias ×−=
Additionally, in order to verify and guarantee 
the response of the method, it was performed an 
additional accuracy experiment using the coumarin 
standard in ethanol at the concentrations 0.125, 0.250 
and 0.500 mg/mL.
Recovery studies for the plant raw material 
were carried out in quadruplicate on both coumarin and 
piperonal, followed by two injections of each sample. 
For this procedure, 20.0 g of powdered leaves and branch 
tips were extracted with ethyl acetate using a soxhlet 
extractor apparatus until total extraction of coumarin. 
After that, the plant material, free of coumarin, was 
carefully dried. Then, three different concentrations 
of coumarin were incorporated into the plant material 
(0.500 g) using 2.5, 5.0 and 10.0 mg of coumarin, 
respectively plus about 2.0 mL of ethyl acetate. After 
complete homogenization, the organic solvent was 
eliminated, and 20.0 mL of ethanol containing 200 µg/
mL of piperonal were added to all samples, which were 
processed as described in sample preparation section. 
The samples were filtered and aliquots of 5 mL from 
each one were transferred to flasks containing 2.0 mL 
of a 500 µg/mL of another internal standard solution, 
1,2,3,4-tetramethylbenzene, which was not submitted 
to the extraction procedure. It was added just before 
injection of the sample into the GC apparatus, allowing 
the quantification of both coumarin and piperonal. 
The syrup recovery studies were undertaken 
in three batches by extracting a sample containing 
only the standard coumarin at a concentration of 0.26 
mg/g, instead of guaco extract. For that, 10.0 g of the 
prepared syrup plus 20.0 mL of ethyl acetate, containing 
100 µg/mL of piperonal, were transferred to a 50.0 mL 
Erlenmeyer flask, and submitted to extraction using a 
magnetic stirrer for 30 min at 40 ºC. The samples were 
cooled down to room temperature, filtered and analyzed 
in duplicate. 
RESULTS AND DISCUSSION
Like for all pharmaceutical products, in order 
to guarantee the quality, efficacy and safety for the 
human use of M.	glomerata, it is mandatory to employ 
validated analytical methods for the quantification of 
coumarin as the major chemical marker in both raw 
material and commercial products.
The developed capillary gas chromatographic 
method proved to be simple, specific, and reproducible 
for the quantitative analysis proposed. Following the 
described chromatographic parameters, coumarin was 
accurately quantified in guaco syrup, as well as in plant 
material and its extract. 
Performing the specificity test, it was found, 
for all samples, that there was no compound interfering 
neither with the peak of coumarin nor with the 
peaks of the internal standards piperonal and 1, 2, 3, 
4-tetramethylbenzene, which were chosen because 
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of their solubility, good recovery and excellent linear 
response. Also, an excellent separation could be 
Figure 1. Chromatographic profile of guaco samples: 
(A) standard mix; (B) syrup; (C) extract; (D) dried 
leaves; (1) piperonal; (2) 1,2,3,4-tetramethylbenzene; (3) 
1,2-benzopyrone (coumarin). For chromatographic conditions 
please see Material and Methods: Chromatographic conditions.
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Figure 2. Stability of the three batches of guaco syrup at 0, 
30, 60, 90 and 180 days under stress conditions: 40 °C ± 2 °C 
and 75 % RH ± 5 %. 
achieved with a good resolution. According to Green 
(1996) it was acceptable a resolution greater than 1.5, 
as occurred. Figure 1 also displays the chromatographic 
profile of all samples analyzed. 
As reported in previous work by Bastos et al. 
(2006), for the dehydrated plant sample, the extraction 
for one hour at 40 °C was found to be enough to extract all 
the coumarin content. However, two hours of extraction 
were chosen to ensure the extraction of the total amount 
of coumarin, as determined by the application of several 
laboratory assays. The sample size was established at 
0.500 g to facilitate the routine analysis of guaco, and 
to diminish manipulation errors. Ethanol was chosen 
as extracting solvent not only because of its use in 
the preparation of the extract by the companies, but 
also because it worked very well in the developed 
protocol. Besides, this solvent is safe for both human 
and environment, cheap and less volatile. Regarding the 
syrup extraction, ethyl acetate was chosen because of its 
selective extraction of coumarin, which was carried out 
for 30 min at 40 ºC, using a magnetic stirrer, allowing 
the use of low amount of the syrup sample.  
In order to certify the system conformity, it 
was tested the accuracy of an ethanol coumarin standard 
solution, which was determined to be 101.9 % (data 
not shown). Later, the recovery of coumarin using the 
developed procedure was considered to be excellent for 
dehydrated plant material and syrup. 
For plant raw material the accuracy was 
determined in three concentration levels, with four 
replicates, for which the highest relative standard 
deviation (% RSD) was found to be 1.37 % (Table 
1), with average accuracy (BIAS) of 2.775, 1.510 and 
0.629, respectively. The obtained recoveries for the 
coumarin and the internal standard piperonal were 101.6 
% and 95.1 % respectively.
 The accuracy determined for the syrup was 
performed in six replicates at a concentration of 0.260 
mg/g, for which the obtained % RSD was 1.31 %, with 
average accuracy (BIAS) of 0.897. The recovery was 
determined as 100.8 % (data not shown).
The results of the precision experiments are 
presented in Table 2. It can be inferred that the method 
is in agreement among individual test results when the 
procedure is applied repeatedly to multiple samples. 
The relative standard deviation for all the samples was 
lower than 2.5 %. At least, for the established parameters 
obtained for coumarin, a LOQ of 1.5 µg/mL and a LOD 
of 0.5 µg/mL were found. 
Concerning the quantitative analysis, it was 
found 0.38 % w/w of coumarin in the plant raw material. 
In previous work, according to Vilegas et al. (1997a), it 
was found 0.44 % w/w of coumarin in the leaves by GC 
analysis. These results are quite in agreement, since the 
coumarin content may vary according to seasonality and 
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site plant harvesting, as well as the storage conditions. 
For the extract, it was found 1.33 mg/mL of coumarin. 
Regarding the syrup, according to ANVISA (Brasil, 
2004), the daily recommended coumarin dosage is 
between 0.525 - 4.89 mg. It was found that, the average 
of coumarin content in each milliliter of guaco syrup 
was 0.143 mg. Hence, ten milliliters of this syrup 
provides 1.43 mg of coumarin per dosage, meeting both 
the efficacy and safety requirements for the use of this 
formulation. For this reason, another important aim of 
the developed method was to allow the analysis of the 
final phytomedicines, especially when the samples were 
kept under stress conditions, such as high temperatures 
and humidity. For that, five individual samples of three 
batches of syrup prepared were submitted to periods of 
0, 30, 60, 90 and 180 days of stress in a climate chamber 
at 40 °C ± 2 °C and 75 % RH ± 5 %. Afterwards, the 
samples were analyzed using the developed method 
(Figure 2). It was observed that there is a slightly 
decrease in concentration of coumarin along the 
undertaken stress experiment.
The data presented shows that the developed 
method is suitable for the routinely quantitative analysis 
of coumarin in guaco syrup, as well as in plant raw 
material and in its extract. Besides, it is important 
to point out that the developed sample preparation 
allows the reliable quantitative analysis of coumarin 
compound in a complex matrix containing sugar by 
gas chromatography, as demonstrated by the described 
validation procedure. 
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